Sr Manager, PO Product Strategy

Abbott•San Diego, CA
•$129,300 - $258,700

About The Position

The Senior Manager is the accountable product strategy and product management lead for Oncotype DX in invasive breast cancer. The role sets franchise strategy and the multi-year roadmap, owns the forecasts and business cases behind it, and leads cross-functional teams from concept through launch and across the in-market lifecycle. The role also represents Oncotype DX within the Abbott Cancer Diagnostics Oncology multi-product offering alongside Oncodetect, OncoExTra, and Riskguard. The role owns global strategy and business performance, translates strategy into a prioritized product roadmap, and leads programs through stage-gate development. It manages the in-market test lifecycle, partners on positioning and launch readiness, and sets guideline and market-access strategies. It also monitors competitors, evaluates business-development opportunities, aligns US and international plans, leads and develops cross-functional teams and direct reports, and supports compliance with the Quality Management System and applicable regulatory requirements. The position is based in the United States, with listed locations in Madison, Wisconsin and La Jolla, California. It involves standard work shift and travel approximately 15% of the time. Significant work activities include prolonged sitting and keyboard use for at least 50% of the workday.

Requirements

  • Bachelor’s degree in life sciences, business, or a related field.
  • 10+ years of relevant experience in diagnostics, biopharma, medical device, or healthcare strategy consulting, or 8+ years with an advanced degree.
  • Relevant experience must include at least two of the following: product management, product or portfolio strategy, upstream marketing, market access, business development, or commercialization.
  • 5+ years leading people or cross-functional project teams.
  • Experience taking a product through a stage-gated development process to launch, or leading a major change to an in-market product.
  • Strong financial modeling skills, including forecasts, P&L, and NPV/IRR-based business cases.
  • Ability to turn complex clinical, commercial, and financial information into clear recommendations for senior leaders.

Nice To Haves

  • Advanced degree (MBA, PhD, MS, PharmD, or MD) in life sciences, business, or a related field.
  • Oncology diagnostics experience; breast cancer and gene expression or genomic testing experience are strongly preferred.
  • Working knowledge of LDT (CLIA/CAP), FDA, EU IVDR, and Japan PMDA pathways.
  • Experience with US molecular diagnostics reimbursement, including MolDX, CLFS, coding, and payer coverage, and with evidence programs such as real-world evidence and clinical or economic utility studies.
  • Experience developing or commercializing products outside the United States.
  • Experience in both clinical (HCP-facing) and laboratory settings.

Responsibilities

  • Own the global Oncotype DX strategy and multi-year roadmap, balancing the core HR+/HER2- early breast cancer indication with expansion into new clinical uses and markets.
  • Lead Oncotype DX inputs to the annual operating plan, forecast updates, and long-range plan, including volume, average selling price, revenue, and market-share scenarios.
  • Analyze order, sales, and market data and convert findings into actions with Commercial and Business Delivery.
  • Build ROI-based business cases, including P&L, NPV, and IRR analyses, and recommend whether to continue, stop, or sunset franchise investments.
  • Translate franchise strategy into a prioritized roadmap of enhancements and next-generation versions, with target product profiles, business requirements, and success measures.
  • Lead Oncotype DX programs through the stage-gate development process, owning business cases and gate recommendations from concept through launch.
  • Partner with R&D, Clinical, Regulatory, Quality, Lab Operations, and IT to deliver product changes across US LDT and ex-US regulated markets, including EU IVDR and Japan PMDA pathways.
  • Manage the in-market test lifecycle, including report content and design, ordering experience, sample requirements, and turnaround time.
  • Partner with Marketing, Sales, and Customer Experience on positioning, messaging, launch readiness, and field training.
  • Plan product-version transitions and retirements to protect customers, coverage, and lab operations.
  • Set guideline strategy with Medical Affairs, including NCCN submission planning.
  • Partner with Market Access on coverage, coding, and pricing strategy to protect Recurrence Score coverage and secure reimbursement for new product versions.
  • Monitor the competitive landscape and lead rapid-response planning with Market Intelligence, Medical Affairs, and Legal, including intellectual property considerations.
  • Assess partnering, licensing, and collaboration opportunities, including technology partners, biopharma collaborations, and access to trial samples.
  • Represent Oncotype DX in the Abbott Cancer Diagnostics Oncology multi-product offering and drive cross-portfolio synergies with Oncodetect, OncoExTra, and Riskguard in ordering, samples, and reporting.
  • Align US and international strategy with the International business, including product requirements, launch sequencing, and regional regulatory needs.
  • Lead and influence cross-functional teams in a matrixed organization, with or without direct authority.
  • Supervise and develop direct reports by setting goals, organizing and prioritizing work, conducting performance reviews, and building team capability.
  • Prepare and present strategy and decision materials for Precision Oncology leadership and Abbott senior leaders.
  • Support and comply with the Quality Management System and applicable regulatory requirements.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service